Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06974877) titled 'Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load' on May 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Condition:
Cryopyrin-Associated Periodic Syndromes
Amyloidosis
Intervention:
Drug: 124I AT-01
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: May 28, 2025
Target Sample Size: 30 ...